Neuromodulation Devices Market
The neuromodulation market is a relatively small (~$3.3B) segment of the ~$330B (2015) medical devices market that is forecasted to grow at ~7% p.a., reaching ~$4.8B by 2020. Neuromodulation is the alteration of nervous system signals through an electrical current or chemical stimulation to some part of the body with the intent of altering nerve function. Typically, a device and battery are implanted into a patient’s body and programmed by a physician to supply electrical stimulation to the target area under specific parameters (e.g., pulse strength, frequency and duration). The devices have traditionally been used for the treatment of chronic pain, innovations over the last decade have expanded the useful application to a growing assortment of treatment areas, including, but not limited to: voiding dysfunction / urinary and fecal incontinence, Parkinson’s disease, refractory epilepsy, major depression and intractable chronic migraine. This report provides forecasts of the global neuromodulation market and segmentations by target area (spinal cord stimulation [SCS], deep brain stimulation [DBS], sacral nerve stimulation [SNS], vagus nerve stimulation [VNS], gastric electrical stimulation [GES], percutaneous tibial nerve stimulation [PTNS] and peripheral nerve stimulation [PNS]); competitors (Boston Scientific, Cyberonics, Medtronic, St. Jude Medical and emerging players like EnteroMedics, Sapiens Steering Brain Stimulation and Cogentix); geography (North America, Europe, Japan, China, Asia-Pacific and Rest of the World); and indication of use (chronic pain, voiding dysfunction / urinary and fecal incontinence, Parkinson’s disease, refractory epilepsy, essential tremor, dystonia, nausea and vomiting associated with gastroparesis, major depression, obsessive compulsive disorder, intractable chronic migraine and other newer indications like Alzheimer’s disease and obesity). In this report, we discuss emerging technologies (e.g., closed-loop modulation and shaping of electrical current), and also discuss trends in the market, strengths and weaknesses, opportunities and threats, growth drivers and moderators, and regulation. We provide analysis of the major competitors in the space and profiles of their main product lines. Additionally, the report provides analysis of Medicare reimbursement volume and an overview of reimbursement and regulatory protocol across the countries of interest. This report is the product of original research and analysis and contains 292 pages and 72 exhibits of original content. Please visit our website (www.decibio.com) for articles and insights regarding current topics and news in neuromodulation and other life-science areas, as well as additional research reports in related markets including: the worldwide medical device industry, advance wound care, durable medical equipment, companion diagnostics, next generation sequencing, life science research tools, and single cell genomics, among others.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook